logo

biotechnology & drugs News

Share

Galera Therapeutics' Phase 3 ROMAN Trial Of Avasopasem Fails To Meet Primary Endpoint

Genmab Reports Q3 Net Sales Of DARZALEX $1.58 Bln

Radius Health Announces Positive Topline Results From ATOM Study